glioblastoma gene therapy (University of Pennsylvania)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameglioblastoma gene therapy (University of Pennsylvania)
Drug Alias Nameadenoviral gene therapy (University of Pennsylvania)
ClassificationBiologics
Mechanisms of ActionThymidine kinase stimulants
TargetsThymidine kinase
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Pennsylvania
Active IndicationsN/A
Inactive IndicationsGlioma

Other Information

ATC CodeN/A
Related LinksN/A